Zobrazeno 1 - 10
of 41
pro vyhledávání: '"H. Oksefjell"'
Publikováno v:
European Journal of Cancer. 48:2146-2154
The aim of this study was to investigate the impact of surgical approach, the extent of surgery and chemotherapy on overall survival in patients with ovarian carcinoma (OC) stage IV.We retrospectively collected population-based data from the Norwegia
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 91:308-317
Objective. We aimed to evaluate prognostic factors impacting on overall survival during a 20 year period with substantial changes in surgical approach and chemotherapy management of patients with epithelial ovarian carcinoma stage IV. Design. A retro
Autor:
Christina Fotopoulou, Rong Jiang, Philipp Harter, K. Wollschlaeger, H. Oksefjell, Yan Xing, Wen Juan Tian, Jalid Sehouli, Jonathan S. Berek, Ali Ayhan, Catherine Rabbitt, Jacobus Pfisterer, Elena-Ioana Braicu, Dennis S. Chi, Gennaro Cormio, A. du Bois, Claes G. Tropé, Rongyu Zang
Publikováno v:
British Journal of Cancer
Background: This study aims to identify prognostic factors and to develop a risk model predicting survival in patients undergoing secondary cytoreductive surgery (SCR) for recurrent epithelial ovarian cancer. Methods: Individual data of 1100 patients
Autor:
Yan Xing, Ali Ayhan, Jonathan S. Berek, Jalid Sehouli, Wen Juan Tian, A. du Bois, H. Oksefjell, Christina Fotopoulou, Claes G. Tropé, G. P. Breitbach, Rongyu Zang, Dennis S. Chi, Elena-Ioana Braicu, Gennaro Cormio, Catherine Rabbitt, H. G. Meerpohl, P. Harter, Rong Jiang
Publikováno v:
Annals of Surgical Oncology. 19:597-604
To develop a risk model for predicting complete secondary cytoreductive surgery (SCR) in patients with recurrent ovarian cancer. Individual data of 1075 patients with recurrent ovarian cancer undergoing SCR from 7 worldwide centers were pooled and an
Autor:
Alv A. Dahl, Sophie D. Fosså, Claes G. Tropé, Trine Bjøro, H. Oksefjell, Astrid H. Liavaag, Anne Dørum
Publikováno v:
Gynecologic Oncology. 108:348-354
To explore sexual activity and functioning in epithelial ovarian cancer survivors (EOCSs) compared to age-adjusted controls from the general population (NORM) with focus on findings that should be given therapeutic considerations.A cross-sectional st
Publikováno v:
European journal of gynaecological oncology. 32(4)
The aim of this study was to investigate the benefit of cytoreductive surgery (CS) and palliative surgery (PS) because of bowel obstruction in the second relapse (SR) in epithelial ovarian cancer.A retrospective population-based study on recorded inf
Publikováno v:
European journal of gynaecological oncology. 29(6)
The aim of this study on stage I epithelial ovarian cancer (EOC) was to see if our different treatment policies after 1995, when lymph node staging and paclitaxel were introduced, have affected the survival, try to define risk groups for relapse and
Publikováno v:
European journal of gynaecological oncology. 28(4)
The aim of this study was to evaluate the treatment of FIGO Stage IIIC patients who were primarily treated completely or partially at the Norwegian Radium Hospital (NRH) during a 15-year period in order to discover possibilities for improvement of pr
Publikováno v:
European journal of gynaecological oncology. 27(3)
Maximum cytoreduction at primary surgery has been found to be one of the strongest prognostic factors for survival of ovarian cancer. The aim of the study was to investigate the influence of hospital level (primary vs secondary care centre), number a
Autor:
Hans H. Lien, Heidi Lyng, Gunnar B. Kristensen, Olav Kaalhus, R.S. Brovig, Trond Stokke, Kolbein Sundfør, Ruth Holm, H. Oksefjell, D.H. Svendsrud
Publikováno v:
Radiotherapy and Oncology. 78:S60-S61